Intra-cellular Therapies, Inc.
ITCI
Revenue
199.22M
▲23.85M▲13.60%
3 Months ChangeAssets
1.37B
▲42.47M▲3.21%
3 Months ChangeLiabilities
218.45M
▲38.83M▲21.62%
3 Months ChangeFree Cash Flow
-60.07M
▲23.35M▲27.99%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-30
Form 10-Q
ID: 0001628280-24-044196
2024-10-30
Form 8-K
ID: 0001193125-24-247021
2024-08-07
Form 10-Q
ID: 0001628280-24-035386
2024-08-07
Form 8-K
ID: 0001193125-24-195429
2024-06-18
Form 8-K
ID: 0001193125-24-163411
2024-06-18
Form 8-K
ID: 0001193125-24-163038
2024-05-07
Form 10-Q
ID: 0001628280-24-020849
2024-05-07
Form 8-K
ID: 0001193125-24-132586
2024-04-24
Form 8-K
ID: 0001193125-24-110139
2024-04-18
Form 8-K
ID: 0001193125-24-100960